Mark Cohen, MD, FACS

Dr. Cohen is currently Assistant Professor of Surgery, Pharmacology, Toxicology and Therapeutics at the University of Kansas. He received his medical degree in 1998 from Washington University School of Medicine in St. Louis and completed his general surgery residency as well as a NIH sponsored fellowship in endocrine and oncologic surgery at Barnes Hospital. His clinical interests include endocrine surgery specifically thyroid surgery, minimally invasive parathyroid surgery and adrenalectomy, as well as surgery for melanomas, sarcomas and a variety of general surgery problems. He is Boarded by the American Board of Surgery and is a Fellow of the American College of Surgeons.

In addition to his clinical interests, Dr. Cohen has an active basic science and translational research laboratory combining interests from the Department of Surgery, the Department of Pharmacology, Toxicology and Therapeutics, and the Department of Biochemistry at the Medical Center, as well as the Departments of Medicinal Chemistry and Pharmaceutical Chemistry on the Lawrence Campus. His research focuses on targeted cancer-drug development and drug delivery systems in thyroid cancer, melanoma, breast cancer and colon cancer. He is coursemaster for the “Introduction to Translational Research” course at the graduate and medical schools and is a member of the KU Cancer Center, the Surgical Research Committee, the Human Studies Committee, and the Admissions Committee for the School of Medicine.